Status:
COMPLETED
Behavioral Drug and HIV Risk Reduction Counseling in Methadone Patients in China
Lead Sponsor:
Yale University
Collaborating Sponsors:
National Institute on Drug Abuse (NIDA)
Conditions:
Opiate Dependence
HIV Infections
Eligibility:
All Genders
20+ years
Phase:
PHASE3
Brief Summary
A randomized clinical trial evaluating the reduction of HIV risk behaviors and drug use when providing integrated behavioral drug and HIV risk reduction counseling (BDRC) along with methadone maintena...
Detailed Description
This project is a supplement to a parent grant, Drug Counseling and Abstinence-Contingent Take-Home Buprenorphine in Malaysia. The specific aims of the parent grant include evaluating whether the rela...
Eligibility Criteria
Inclusion
- opioid dependence
Exclusion
- current dependence on alcohol, benzodiazepines or sedatives
- current suicide or homicide risk
- current psychotic disorder or untreated major depression
- life-threatening or unstable medical problems
Key Trial Info
Start Date :
September 1 2007
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 1 2010
Estimated Enrollment :
45 Patients enrolled
Trial Details
Trial ID
NCT00757744
Start Date
September 1 2007
End Date
September 1 2010
Last Update
March 30 2020
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Yale University School of Medicine - CMHC
New Haven, Connecticut, United States, 06520
2
Wuhan Center for Disease Control and Prevention
Wuhan, Hubei, China